Viewing Study NCT04982068


Ignite Creation Date: 2025-12-24 @ 5:43 PM
Ignite Modification Date: 2026-01-04 @ 10:16 AM
Study NCT ID: NCT04982068
Status: UNKNOWN
Last Update Posted: 2023-04-19
First Post: 2021-07-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19
Sponsor: Shanghai Zerun Biotechnology Co.,Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module